323 related articles for article (PubMed ID: 24418478)
21. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.
Matangkasombut P; Pichavant M; Saez DE; Giliani S; Mazzolari E; Finocchi A; Villa A; Sobacchi C; Cortes P; Umetsu DT; Notarangelo LD
Blood; 2008 Jan; 111(1):271-4. PubMed ID: 17890453
[TBL] [Abstract][Full Text] [Related]
22. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
[TBL] [Abstract][Full Text] [Related]
23. Compound heterozygous mutation of Rag1 leading to Omenn syndrome.
Matthews AG; Briggs CE; Yamanaka K; Small TN; Mooster JL; Bonilla FA; Oettinger MA; Butte MJ
PLoS One; 2015; 10(4):e0121489. PubMed ID: 25849362
[TBL] [Abstract][Full Text] [Related]
24. Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
Ital J Pediatr; 2012 Mar; 38():8. PubMed ID: 22424479
[TBL] [Abstract][Full Text] [Related]
25. HyperIgE in hypomorphic recombination-activating gene defects.
Castiello MC; Brandas C; Capo V; Villa A
Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
[TBL] [Abstract][Full Text] [Related]
26. RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.
Bosticardo M; Pala F; Notarangelo LD
Eur J Immunol; 2021 May; 51(5):1028-1038. PubMed ID: 33682138
[TBL] [Abstract][Full Text] [Related]
27. Immunological assessment of a patient with Omenn syndrome resulting from compound heterozygous mutations in the RAG1 gene.
Mou W; Yang Z; Wang X; Hei M; Wang Y; Gui J
Immunogenetics; 2023 Aug; 75(4):385-393. PubMed ID: 37269334
[TBL] [Abstract][Full Text] [Related]
28. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.
Pasic S; Djuricic S; Ristic G; Slavkovic B
Acta Paediatr; 2009 Jun; 98(6):1062-4. PubMed ID: 19243569
[TBL] [Abstract][Full Text] [Related]
29. Omenn syndrome caused by a novel homozygous mutation in recombination activating gene 1.
Benhsaien I; Essadssi S; Elkhattabi L; Bakhchane A; Abdelghaffar H; Bousfiha AA; Badou A; Barakat A
Immunobiology; 2021 May; 226(3):152090. PubMed ID: 33964732
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
[No Abstract] [Full Text] [Related]
31. RAG1 deficiency may present clinically as selective IgA deficiency.
Kato T; Crestani E; Kamae C; Honma K; Yokosuka T; Ikegawa T; Nishida N; Kanegane H; Wada T; Yachie A; Ohara O; Morio T; Notarangelo LD; Imai K; Nonoyama S
J Clin Immunol; 2015 Apr; 35(3):280-8. PubMed ID: 25739914
[TBL] [Abstract][Full Text] [Related]
32. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.
Wada T; Takei K; Kudo M; Shimura S; Kasahara Y; Koizumi S; Kawa-Ha K; Ishida Y; Imashuku S; Seki H; Yachie A
Clin Exp Immunol; 2000 Jan; 119(1):148-55. PubMed ID: 10606976
[TBL] [Abstract][Full Text] [Related]
33. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency.
Kumaki S; Villa A; Asada H; Kawai S; Ohashi Y; Takahashi M; Hakozaki I; Nitanai E; Minegishi M; Tsuchiya S
Blood; 2001 Sep; 98(5):1464-8. PubMed ID: 11520796
[TBL] [Abstract][Full Text] [Related]
34. Characterization of T and B cell repertoire diversity in patients with RAG deficiency.
Lee YN; Frugoni F; Dobbs K; Tirosh I; Du L; Ververs FA; Ru H; Ott de Bruin L; Adeli M; Bleesing JH; Buchbinder D; Butte MJ; Cancrini C; Chen K; Choo S; Elfeky RA; Finocchi A; Fuleihan RL; Gennery AR; El-Ghoneimy DH; Henderson LA; Al-Herz W; Hossny E; Nelson RP; Pai SY; Patel NC; Reda SM; Soler-Palacin P; Somech R; Palma P; Wu H; Giliani S; Walter JE; Notarangelo LD
Sci Immunol; 2016 Dec; 1(6):. PubMed ID: 28783691
[TBL] [Abstract][Full Text] [Related]
35. The Clinical and Genetic Spectrum of 82 Patients With
Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
Front Immunol; 2020; 11():900. PubMed ID: 32655540
[No Abstract] [Full Text] [Related]
36. Partial V(D)J recombination activity leads to Omenn syndrome.
Villa A; Santagata S; Bozzi F; Giliani S; Frattini A; Imberti L; Gatta LB; Ochs HD; Schwarz K; Notarangelo LD; Vezzoni P; Spanopoulou E
Cell; 1998 May; 93(5):885-96. PubMed ID: 9630231
[TBL] [Abstract][Full Text] [Related]
37. A variant of RAG1 gene identified in severe combined immunodeficiency: a case report.
Zhang X; Kang X; Yang M; Cai Z; Song Y; Zhou X; Cao J; Wang C; Huang K; Peng Y; He J; Xiao Z
BMC Pediatr; 2023 Feb; 23(1):56. PubMed ID: 36732712
[TBL] [Abstract][Full Text] [Related]
38. Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination.
Li W; Chang FC; Desiderio S
Mol Cell Biol; 2001 Jun; 21(12):3935-46. PubMed ID: 11359901
[TBL] [Abstract][Full Text] [Related]
39. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
[TBL] [Abstract][Full Text] [Related]
40. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]